Impact of vitamin D supplementation on the outcome of tuberculosis treatment: A systematic review and meta-analysis of randomized controlled trials

Chinese Medical Journal

Volumn 127, Issue 17, 2014, Pages 3127-3134

  Xia, Jing Yan ^a   Shi, Li Yun ^b   Zhao, Lifang ^a   Xu, Feng ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HANGZHOU NORMAL UNIVERSITY   (China)

Author keywords

Meta Analysis; Randomized controlled trials; Systematic review; Tuberculosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; VITAMIN D;

ARTICLE; BODY WEIGHT; HUMAN; META ANALYSIS; MULTICENTER STUDY (TOPIC); PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SPUTUM CULTURE; SPUTUM SMEAR; TREATMENT OUTCOME; TUBERCULOSIS; VITAMIN D SUPPLEMENTATION; VITAMIN SUPPLEMENTATION; BLOOD; DIET SUPPLEMENTATION;

DIETARY SUPPLEMENTS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TUBERCULOSIS; VITAMIN D;

EID: 84906963519     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20140702     Document Type: Article

References (33)

1. WHO: Global tuberculosis control: WHO report. (Accessed November 4, 2012 at http:// www.who.int/iris/ handle/10665/75938).
2. Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One 2011; 6: e17601.
3. Dini C, Bianchi A.The potential role of vitamin D for prevention and treatment of tuberculosis and infectious diseases. Ann Ist Super Sanita 2012; 48: 319-327.
4. Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ. Vitamin D in the treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol 2007; 103: 793-798.
5. Maartens G, Wilkinson RJ. Tuberculosis. Lancet 2007; 370: 2030-2043.
6. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-1773.
7. Antal AS, Dombrowski Y, Koglin S, Ruzicka T, Schauber J. Impact of vitamin D3 on cutaneous immunity and antimicrobial peptide expression. Dermatoendocrinol 2011; 3: 18-22.
8. Sly LM, Lopez M, Nauseef WM, Reiner NE. 1alpha, 25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem 2001; 276: 35482-35493.
9. Rockett KA, Brookes R, Udalova I, Vidal V, Hill AV, Kwiatkowski D. 1, 25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 1998; 66: 5314-5321.
10. Rook GA, Steele J, Fraher L, Barker S, Karmali R, O’Riordan J, et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986; 57: 159-163.
11. Selvaraj P, Chandra G, Jawahar MS, Rani MV, Rajeshwari DN, Narayanan PR. Regulatory role of vitamin D receptor gene variants of Bsm I, Apa I, Taq I, and Fok I polymorphisms on macrophage phagocytosis and lymphoproliferative response to mycobacterium tuberculosis antigen in pulmonary tuberculosis. J Clin Immunol 2004; 24: 523-532.
12. Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011; 377: 242-250.
13. Wejse C, Gomes VF, Rabna P, Gustafson P, Aaby P, Lisse IM, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009; 179: 843-850.
14. Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006; 38: 3-5.
15. Salahuddin N, Ali F, Hasan Z, Rao N, Aqeel M, Mahmood F, Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study (Supplementary Cholecalciferol in recovery from tuberculosis). A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis. BMC Infect Dis 2013; 13: 22.
16. Morcos MM, Gabr AA, Samuel S, Kamel M, el Baz M, el Beshry M, et al. Vitamin D administration to tuberculous children and its value. Boll Chim Farm 1998; 137: 157-164.
17. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
18. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
19. Tobias A. Assessing the influence of a single study in meta-analysis. Stata Tech Bull 1999; 47: 15-17.
20. Sharp S. Meta-analysis regression. Stata Tech Bull 1998; 42:16-22.
21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
22. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56: 455-463.
23. Martineau AR, Nhamoyebonde S, Oni T, Rangaka MX, Marais S, Bangani N, et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci USA 2011; 108: 19013-19017.
24. Maclachlan JH, Lavender CJ, Cowie BC. Effect of latitude on seasonality of tuberculosis, australia, 2002-2011. Emerg Infect Dis 2012; 18: 1879-1881.
25. Grant WB. Variations in vitamin D production could possibly explain the seasonality of childhood respiratory infections in Hawaii. Pediatr Infect Dis J 2008; 27: 853.
26. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006; 134: 1129-1140.
27. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008; 37: 113-119.
28. Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, Kim KK, et al. Vitamin D3 induces autophagy in human monocytes/ macrophages via cathelicidin. Cell Host Microbe 2009; 6: 231-243.
29. Gao L, Tao Y, Zhang L. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis 2010; 14: 15-23.
30. Sinclair D, Abba K, Grobler L, Sudarsanam TD. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev 2011; 9: CD006086.
31. Rahimi K, Emberson J, McGale P, Majoni W, Merhi A, Asselbergs FW, et al. Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. BMJ 2011; 342: d1250.
32. Granger CB, Vogel V, Cummings SR, Held P, Fiedorek F, Lawrence M, et al. Do we need to adjudicate major clinical events? Clin Trial 2008; 5: 56-60.
33. Pogue J, Walter SD, Yusuf S. Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs. Clin Trial 2009; 6: 239-251.